Search fresh public links, source activity, and ready-to-use post angles for Cerenovus.
Fresh curated links around Cerenovus are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Cerenovus Division Anonymous (not verified) Sat, 09/26/2026 - 00:59 field_thread_url https://cafepharma.com/boards/threads/cerenovus-division.685354/...
Cerenovus Division Anonymous (not verified) Mon, 09/14/2026 - 18:53 field_thread_url https://cafepharma.com/boards/threads/cerenovus-division.685354/...
Cerevance plans to meet with the FDA to “determine next steps” for a new kind of medicine known as solengepras, now that it has Phase 3 data in hand.
New CT perfusion technology is helping physicians assess brain blood flow and make faster, more informed treatment decisions for stroke patients. Lakeridge Health has introduced ne...
Mount Sinai and Johnson & Johnson will collaboratively evaluate an investigational liquid radioembolic that combines Iodine-131 with TRUFILL n-BCA to embolize and irradiate bra...
~ Submission to the UK MHRA for review marks critical step towards initiating a Phase 2 Study with CY200 ~
The two companies now support more than 250 cancer centers—covering more than 100,000 patients—across five countries, executives say.
Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective blood-brain barrier. The deal comes as Novartis weathers...
Proceeds from the deal, which hands Novartis global rights to a technology developed by Sironax, will help advance three candidates that the startup says have “best-in-class” poten...
Novocure Anonymous (not verified) Tue, 09/29/2026 - 01:04 field_thread_url https://cafepharma.com/boards/threads/novocure.589782/ board...
The once-daily oral therapy is available in five strengths, with clinical studies showing reductions in seizure frequency among adults with uncontrolled focal seizures
Novocure Anonymous (not verified) Tue, 10/20/2026 - 13:14 field_thread_url https://cafepharma.com/boards/threads/novocure.589782/ board...
Aspen Neuroscience is looking to join the Nasdaq and raise more money to support its lead program, which aims to turn a patient's own cells into dopamine-producing neurons.
(World Oil) – Cenovus Energy has agreed to acquire Athabasca Oil Corporation in a cash-and-stock transaction valued at approximately C$5.7 billion […]
A sweeping review published in the Journal of Neurology charts how a small mesh-like device known as the stent retriever has transformed the treatment of acute ischemic stroke, and...
HN Summary • A major Canadian AI trial is launching across 13 Ontario hospitals, involving approximately 15,000 patients. • The AI tool predicts which patients are at highest risk...
Veteran medtech executive brings leadership experience across neuromodulation, clinical-stage company building, and commercialization; Founder Kent Leyde to lead technology and pro...
The collaboration will combine technology transfer, clinical and commercial manufacturing, and process optimisation to improve production economics and expand patient access
The struggling cell therapy developer is exploring strategic alternatives, which, among other characteristics, make it a likely candidate to receive reverse merger interest.
Advances GelrinC® U.S. pivotal trial with 43 patients treated; Completion of enrollment expected by approximately year end 2026Expands European commercialization readiness, includi...
Company highlights ongoing clinical developments in traumatic brain injury (TBI) therapeutics and non-invasive cancer screening, sparking key vendor collaboration discussions.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.